You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Eye conditions

Aflibercept for treating choroidal neovascularisation

  • Technology appraisal guidance
  • Reference number: TA486
  • Published:  01 November 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Invitation to participate
  4. Draft scope documents

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 220 KB)

    Published:
    18 January 2018

Final appraisal determination

  • Final appraisal determination

  • Committee papers (PDF 7.72 MB)

    Published:
    22 September 2017
  • Public committee slides (PDF 315 KB)

    Published:
    22 September 2017
  • Final appraisal determination document (PDF 289 KB)

    Published:
    22 September 2017

Invitation to participate

  • Equality impact assessment (Scoping) (PDF 176 KB)

    Published:
    15 March 2017
  • Final scope (PDF 246 KB)

    Published:
    15 March 2017
  • Final matrix (PDF 251 KB)

    Published:
    15 March 2017
  • NICE's response to comments on the draft scope and provisional matrix (PDF 370 KB)

    Published:
    15 March 2017

Draft scope documents

  • Draft scope (pre-referral) (PDF 109 KB)

    Published:
    28 October 2016
  • Provisional matrix (pre-referral) (PDF 36 KB)

    Published:
    28 October 2016
Back to top